Survodutide - Novel Anti Obesity Drug
Survodutide (BI 456906) is a novel, dual agonist of glucagon and glucagon-like peptide-1 (GLP-1) receptors developed as a once-weekly subcutaneous injection for the management of obesity. While GLP-1 receptor agonists have shown promise in managing obesity and associated complications, survodutide...
Furkejuvvon:
| Váldodahkkit: | , , , , |
|---|---|
| Materiálatiipa: | Artigo |
| Giella: | Inglês |
| Almmustuhtton: |
Dr. Annil Mahajan
2025-01-01
|
| Ráidu: | JK Science |
| Fáttát: | |
| Liŋkkat: | https://journal.jkscience.org/index.php/JK-Science/article/view/344 |
| Fáddágilkorat: |
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|